Viseven

What does a mature pharma content operation actually look like? We analysed 6,856 content workflows across 20+ enterprise pharma companies to understand how organizations manage content across the full lifecycle, and what separates different levels of maturity. Take the Assessment to find out where your content operation stands on the maturity journey, and get the full State of Content Operations research to explore the data behind the benchmark. Take the Assessment & Get the Research.

How much of your content operation is spent managing compliance rather than moving content forward? Our research found that 32% of workflow activity goes into review, approval, version control and documentation. Take the assessment and download the State of Content Operations research to see how compliance fits into the wider pharma content workflow, and what the data reveals about operational maturity.

How much value is pharma leaving on the table after content gets approved? Our State of Content Operations research analyses 6,856 workflows across 20+ enterprise pharma companies to reveal where content operations stand today: from production and approval to reuse and activation. Take the assessment and download the research to explore the data and see the key gaps shaping pharma content operations.

As European marketing teams navigate tight budgets and strict regulatory frameworks, traditional agency delivery models are undergoing a fundamental shift. Catch Nataliya Andreychuk and Tim Pantello on 𝐏𝐡𝐚𝐫𝐦𝐚𝐓𝐚𝐥𝐤𝐬 as they explore how AI agents are joining human teams inside compliant content supply chains: 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐯𝐞 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐬: How editors, copywriters, and AI agents co-create content in a structured, traceable environment. 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐨𝐧 𝐀𝐈 𝐨𝐯𝐞𝐫 𝐜𝐨𝐝𝐞: How intuitive AI interfaces allow teams to orchestrate campaigns without heavy technical overhead. 𝐑𝐞𝐝𝐞𝐟𝐢𝐧𝐢𝐧𝐠 𝐚𝐠𝐞𝐧𝐜𝐲 𝐬𝐮𝐩𝐩𝐨𝐫𝐭: Why agency partnerships are shifting from manual production to AI-driven, high-velocity orchestration. Viseven bridges the gap between pharma brands and agencies across EMEA, offering an integrated modular ecosystem that powers human-AI collaboration while maintaining strict compliance. 👉 Watch the teaser snippet below and access the full episode here: https://lnkd.in/dpjg-2Es

To innovate safely within Europe's strict regulatory environment, AI systems require the same clarity, boundaries, and performance metrics as human teams. Watch this clip from 𝐏𝐡𝐚𝐫𝐦𝐚𝐓𝐚𝐥𝐤𝐬 to discover how establishing structured management for Agentic AI unlocks true operational transformation: 𝐂𝐥𝐞𝐚𝐫 𝐛𝐨𝐮𝐧𝐝𝐚𝐫𝐢𝐞𝐬 𝐚𝐧𝐝 𝐊𝐏𝐈𝐬: Why AI performs at its best when given explicit guardrails, objectives, and success metrics. 𝐑𝐞𝐢𝐦𝐚𝐠𝐢𝐧𝐢𝐧𝐠 𝐩𝐫𝐨𝐜𝐞𝐬𝐬𝐞𝐬: Moving past minor process tweaks to rebuild European content supply chains from scratch. 𝐒𝐭𝐫𝐮𝐜𝐭𝐮𝐫𝐞𝐝 𝐠𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞: Treating AI as a managed workforce to ensure total compliance while driving speed to market. Viseven provides the governance framework and modular content architecture EMEA teams need to set precise guardrails, empowering AI agents to scale compliant content safely. 👉 Watch the teaser snippet below and access the full episode here: https://lnkd.in/dsvhYUeU

Across European life sciences, ethical AI and responsible data usage are paramount. Yet algorithms are only as unbiased as the humans who build and train them. Watch Anna and Nataliya Andreychuk on 𝐏𝐡𝐚𝐫𝐦𝐚𝐓𝐚𝐥𝐤𝐬 as they explore why gender diversity in AI development is a necessity, not an option: 𝐁𝐞𝐲𝐨𝐧𝐝 𝐭𝐡𝐞 𝐚𝐥𝐠𝐨𝐫𝐢𝐭𝐡𝐦: Why AI behaves like a human system because it reflects human-provided training data. 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐧𝐠 𝐬𝐲𝐬𝐭𝐞𝐦𝐢𝐜 𝐛𝐢𝐚𝐬: How equal representation in tech creation prevents blind spots in data modeling. 𝐇𝐮𝐦𝐚𝐧-𝐜𝐞𝐧𝐭𝐞𝐫𝐞𝐝 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Why inclusive engineering teams build more trustworthy digital ecosystems. Viseven actively fosters diversity across EMEA's tech landscape, delivering human-centric AI solutions that empower life sciences organizations to communicate authentically and equitably. 👉 Watch the teaser snippet below and access the full episode here: https://lnkd.in/dsDxYbZC